Progesterone for menopause · Put the whole plan in view

30 of 30 care reviews

Online care

CoreAge Rx

The published service

Published oral-progesterone offer; exact preparation, personal treatment purpose and care terms need confirmation.

The question explored

A review organized around shared clinical responsibility, surgical history, the estrogen product and unanswered dispensing questions.

Online care

Midi Health

The published service

Menopause clinical care; the review examines the documented service, product identity and continuing care questions.

The question explored

Examine Midi’s relevant clinical service, its published fees and the questions that connect an online visit with existing hormone and bleeding care.

Online care

Evernow

The published service

Online menopause care and progesterone information; a selected product and an individual plan require separate confirmation.

The question explored

A review of the two care models, the full membership amounts and progesterone-page inconsistencies worth resolving with the prescriber.

Online care

Alloy

The published service

Online menopause care with a progesterone pill offer; exact supplied product, IUD-related assessment, treatment rationale and selected purchase remain individual questions.

The question explored

Alloy connects progesterone with uterine protection and includes an IUD qualification; the actual estrogen treatment, history and purchase still require an individual explanation.

Online care

Winona

The published service

Online menopause care for the published age and location range; oral capsules and a compounded combination cream are documented, while personal suitability and protection from the selected preparation are unverified.

The question explored

A capsule listing, a compounded cream and broad uterine-protection language describe different records; convenience cannot establish that their effects are interchangeable.

Online care

Gennev

The published service

Virtual menopause physician and dietitian care; no exact progesterone product, capsule ingredients or universal hormone plan is confirmed by the reviewed records.

The question explored

Gennev combines medical consultations with nutrition support; those appointments have different jobs, and neither a program description nor a symptom list identifies a progesterone plan.

The published service

Virtual menopause prescribing with progesterone named and a separate genitourinary treatment area; exact preparation, insurer payment and person-specific clinical plan are unconfirmed.

The question explored

The service distinguishes broader menopause treatment from vaginal and urinary concerns; its collective product list still does not assign every hormone to every route.

The published service

Menopause clinical care and prescription-transfer options with progesterone capsule entries; exact selected treatment, full payment arrangement and personal applicability remain unverified.

The question explored

Pandia names progesterone capsules and several estrogen formats, while its explanatory examples, care plans and pharmacy routes need to remain separate.

Online care

Stella

The published service

US virtual menopause service with example hormone and nonhormone plans; no universal combination, exact capsule ingredients or personal prescription is confirmed.

The question explored

The US clinic illustrates care with capsules, patches and vaginal cream; its examples need to be read alongside the distinct purposes, visit fees and limits of coaching.

Online care

Wisp

The published service

Online menopause consultation with listed oral hormone options; prescribing depends on assessment and medicines are paid for separately at the selected pharmacy.

The question explored

Wisp publishes an actual menopause consultation and progesterone options; the purpose of a chosen medicine still needs to be distinguished from the broader service menu.

The published service

Online hormone care with capsule and cream listings, separate clinical and medicine charges, and unresolved selected-product and promotional terms.

The question explored

Joi lists progesterone products and broad benefits beyond the uterus; specific clinical exceptions should not be mistaken for a universal reason to buy them.

Online care

Thrivelab

The published service

Online menopause hormone service with progesterone-containing entries in its price list; clinical selection, exact preparation, state access and complete purchase terms require confirmation.

The question explored

Thrivelab’s menopause page leaves the hormone decision with a clinician; its medicine table, testing descriptions and payment terms still require separate interpretation.

Online care

Defy Medical

The published service

US menopause consultation service; location eligibility and the selected medicine require confirmation.

The question explored

A consultation offer, a broad hormone menu and cost averages leave different questions about the reason for progesterone.

Clinic network

BodyLogicMD

The published service

US clinician network; clinician availability, location access and selected treatment are unverified.

The question explored

A network offer and membership pricing should be read alongside the reason for treatment, not as proof of a complete hormone plan.

Clinic network

Renew Youth

The published service

Menopause care program with individual access and exact prescribed formulation still to confirm.

The question explored

Broad progesterone benefits and a low entry offer leave important questions about evidence, preparation and reassessment.

Online care

Hone Health

The published service

Online menopause care; compounded capsule listing does not confirm personal access, formulation or clinical suitability.

The question explored

A compounded capsule listing and broad benefit claims require different evidence from a membership offer.

Online care

Lifeforce

The published service

Online clinical program with state and clinician review; product identity and conflicting plan statements remain unresolved.

The question explored

An extensive benefit description and conflicting membership details do not establish one medicine, goal or follow-up schedule.

Online care

Fountain

The published service

Online care supported by independent medical groups; exact medication, eligibility and personal clinical arrangements require confirmation.

The question explored

Four-week price displays and recurring terms need to be separated from the clinical purpose and review of a hormone plan.

Clinic network

Alpha Hormones

The published service

Care advertised for California, Texas and Florida residents, with Pasadena in-person appointments; individual eligibility and exact product unconfirmed.

The question explored

A published oral progesterone option, package inclusions and recurring terms leave an individual medicine’s purpose to the consultation.

Clinic network

Newson Clinic

The published service

UK private menopause consultations at advertised clinic locations or by video; no US or cross-border prescribing access inferred.

The question explored

UK clinician options and separate appointment prices do not identify the exact progesterone preparation or settle a surgical-history question.

Clinic network

Myla Health

The published service

UK private face-to-face and video menopause care; patients must be on UK soil for consultation, with a UK address for medicine delivery.

The question explored

A UK service describes how advice is communicated, but handing over a letter does not guarantee a continuing prescription.

Health system

Duke Health

The published service

Regional North Carolina menopause evaluation; individual eligibility, medicine and full charges unconfirmed.

The question explored

Duke’s evaluation covers symptoms and other health explanations. Its treatment menu does not establish which progesterone product, if any, a particular consultation would involve.

The published service

Clinic-specific Ohio, Florida and London pathways; location, individual medication appointment and exact product require confirmation.

The question explored

A broad menopause program can address several concerns without making hormone therapy a treatment for every one. Cleveland’s group and individual pathways also require separate clarification.

Health system

Mayo Clinic

The published service

Distinct Minnesota and Florida menopause/sexual-health services; individual access, treatment and payment remain unconfirmed.

The question explored

Mayo describes distinct Minnesota and Florida services. A survivorship or sexual-health consultation does not by itself establish a hormone prescription or its suitability.

The published service

Referral-based regional menopause care; possible Maryland/Florida telemedicine is conditional, with exact medicine and costs unresolved.

The question explored

Hopkins describes referral-based menopause care and connections to other specialties. Coordination does not establish which medicine will be prescribed or why it would belong in a particular plan.

Health system

Mount Sinai

The published service

New York City menopause clinical service; individual assessment, exact preparation, availability and total charges unconfirmed.

The question explored

Mount Sinai lists abnormal bleeding among menopause concerns. Its brief service description confirms clinical care but does not provide a personal explanation, product or treatment adjustment.

The published service

Chicago menopause and sexual-health program; individual access, hormone formulation, pharmacy and total costs not established.

The question explored

Northwestern’s program lists vasomotor, sexual, genitourinary and bleeding concerns. A treatment category does not show that one hormone addresses them all or identify a personal prescription.

Health system

UCLA Health

The published service

UCLA Comprehensive Menopause Program; appointment-specific access, medicine, pharmacy and financial responsibilities require confirmation.

The question explored

UCLA publishes a comprehensive first-visit process and ongoing assessment arrangements. Those program features do not establish a drug monitoring schedule or a reason to continue every medicine.

The published service

Bay Area menopause service with stated video options; geographic eligibility, exact medicine, pharmacy and full cost unconfirmed.

The question explored

Stanford explains progesterone alongside estrogen, but its broad hormone overview is not a personal decision tree. Product exposure, surgery details and clinical context still need clarification.

The published service

University of Utah regional midlife service; surgery-history preparation documented, while individual treatment, access and total costs remain unresolved.

The question explored

Utah publishes preparation questions about hysterectomy and other health history. Those details inform a consultation without becoming a self-directed rule for adding or removing progesterone.